Friday, November 18, 2016

BRIEF-Moleculin Biotech-audit committee determined co's financial statements for quarter ended June 30, 2016 should no longer be relied upon

* Moleculin Biotech - a liability in amount of $750,000

should not have been reflected in balance sheet as of June 30,

2016

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)